SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016622
Filing Date
2023-05-12
Accepted
2023-05-12 16:00:41
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 688021
2 ex31-1.htm EX-31.1 11751
3 ex31-2.htm EX-31.2 11190
4 ex32-1.htm EX-32.1 6000
5 ex32-2.htm EX-32.2 5937
  Complete submission text file 0001493152-23-016622.txt   3829547

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bstg-20230331.xsd EX-101.SCH 29426
7 XBRL CALCULATION FILE bstg-20230331_cal.xml EX-101.CAL 42622
8 XBRL DEFINITION FILE bstg-20230331_def.xml EX-101.DEF 128125
9 XBRL LABEL FILE bstg-20230331_lab.xml EX-101.LAB 254447
10 XBRL PRESENTATION FILE bstg-20230331_pre.xml EX-101.PRE 213051
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 536020
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35853 | Film No.: 23915398
SIC: 3841 Surgical & Medical Instruments & Apparatus